Expertise in
2
conditions

Dr. Mark H. Gotfried

Pulmonary Medicine
3811 E Bell Rd Ste 107, 
Phoenix, AZ 
Accepting New Patients
Offers Telehealth
Expertise in
2
conditions
3811 E Bell Rd Ste 107, 
Phoenix, AZ 

Overview

Mark Gotfried is a Pulmonary Medicine provider practicing medicine in Phoenix, Arizona.

Dr. Gotfried is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Nocardiosis, and Excessive Daytime Sleepiness.

Dr. Gotfried is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 7 clinical trials. Dr. Gotfried is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in AZ

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Arizona College of Medicine

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Pulmonary Associates
3811 E Bell Rd Ste 107, Phoenix, AZ 85032
Other Locations
Pulmonary Associates
10585 N Tatum Blvd Ste D130, Paradise Valley, AZ 85253
Pulmonary Associates
9225 N 3rd St Ste 205, Phoenix, AZ 85020

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drug: Trans Sodium Crocetinate
Study Phase: Phase 2
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
BIG4 - CPAP Educational Materials and Usage Feedback to Promote CPAP Adherence
Enrollment Status: Completed
Publish Date: April 05, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects
A Phase I Study to Determine and Compare Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Intravenous ETX2514 and Sulbactam Administered to Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: November 09, 2017
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

40 Total Publications

Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects.
Plasma and intrapulmonary pharmacokinetics of funobactam, a novel diazabicyclooctane β-lactamase inhibitor, administered in combination with imipenem/cilastatin in healthy subjects.
Journal: Antimicrobial agents and chemotherapy
Published: June 15, 2026
Similar Doctors
Expertise in
24
conditions
Dr. Rajat Walia
Pulmonary Medicine | Transplant Surgery
Expertise in
24
conditions
Dr. Rajat Walia
Pulmonary Medicine | Transplant Surgery
Referral required
Before you request

Sjhmc Physician Services

3555 S Val Vista Dr, 
Gilbert, AZ 
 (27.5 miles away)
480-728-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

The Center for Thoracic Disease and Transplantation at the Heart & Lung Institute believes in treating all patients with dignity and respect. Using a multidisciplinary approach, the Center works to diagnose and treat some of the most complex thoracic and esophageal diseases in the Southwest through a team of physicians who provide patients with a plan of care. Patients receive treatment with state-of-the-art technology to ensure a full range of treatment options.We offer treatment and care in accordance with national guidelines. Dr. Walia is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Lung Transplant, and Tissue Biopsy. Dr. Walia is board certified in Internal Medicine (Sub: Critical Care Medicine), Internal Medicine, and Internal Medicine (Sub: Pulmonary Disease). Dr. Walia is currently accepting new patients.

Expertise in
16
conditions
Dr. Rajeev C. Saggar
Pulmonary Medicine
Expertise in
16
conditions
Dr. Rajeev C. Saggar
Pulmonary Medicine
Referral may be required
Before you request

Banner-University Super Specialists LLC

755 E McDowell Rd Fl 4, 
Phoenix, AZ 
 (11.4 miles away)
602-255-7600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Rajeev Saggar is a Pulmonary Medicine provider practicing medicine in Phoenix, Arizona. Dr. Saggar is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Saggar is currently accepting new patients.

Expertise in
15
conditions
Dr. Jeremy P. Feldman
Pulmonary Medicine
Expertise in
15
conditions
Dr. Jeremy P. Feldman
Pulmonary Medicine
Referral may be required
Before you request

St. Joseph's Hospital And Medical Center

350 W Thomas Rd, 
Phoenix, AZ 
 (11.0 miles away)
602-443-0184
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremy Feldman is a Pulmonary Medicine provider practicing medicine in Phoenix, Arizona. Dr. Feldman is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Pulmonary Fibrosis, Gastrostomy, and Splenectomy. Dr. Feldman is currently accepting new patients.

Frequently Asked Questions about Dr. Mark H. Gotfried

How do I make an appointment with Dr. Mark H. Gotfried?

You can book an appointment with Dr. Mark H. Gotfried by calling their office at 602-340-1689. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark H. Gotfried a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark H. Gotfried is classified as an Advanced expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark H. Gotfried specialize in?

While Dr. Mark H. Gotfried is a Pulmonary Medicine, they have specific expertise in Emphysema, Chronic Obstructive Pulmonary Disease (COPD), and Pulmonary Nocardiosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Mark H. Gotfried participate in research or clinical trials?

Yes. Dr. Mark H. Gotfried has published 40 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Mark H. Gotfried's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark H. Gotfried accept my insurance?

Dr. Mark H. Gotfried accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 602-340-1689 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gotfried's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile